News | December 09, 2022
Emmes launches Cell and Gene Therapy Center
The new center will focus on supporting the clinical trials clients who are developing cell and gene therapies
The new center will focus on supporting the clinical trials clients who are developing cell and gene therapies
Under the terms of this agreement Biocon will be responsible for the manufacturing and supply of Liraglutide to Zentiva, for its commercialization across 30 countries in Europe
The company sees the business reaching $100mn
Nikon’s newly launched product AXR Point scanning confocal microscope provides “World’s largest Field of View” of 25mm in one single shot
Frazier led the company for 10 years as President and Chief Executive Officer, from 2011 through 2021.
The TBDA is a collaboration established among biopharmaceutical companies, research organizations and universities to accelerate the discovery and development of novel therapeutic candidates against TB.
In Q2 FY23, the overall performance of the company continued to be strong despite the ongoing geo-political challenges impacting supply chain and costs
New material distribution will serve medical device and pharmaceutical packaging manufacturers.
This recognition marks the third time in five years that Merck has been included on Fortune’s Change the World list.
Through this agreement, Lupin will introduce two new formulations, a fixed-dose combination of Rifapentine + Isoniazid and Rifapentine 300 mg standalone tablets, at an affordable price
Subscribe To Our Newsletter & Stay Updated
